| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
ALK-positive large B-cell lymphoma, a rare B-cell lymphoma expressing ALK
|
Nahmod, Karen A.
|
|
|
141 |
2 |
p. 209
|
article
|
| 2 |
A randomized clinical trial of the efficacy and safety of rivipansel for sickle cell vaso-occlusive crisis
|
Dampier, Carlton D.
|
|
|
141 |
2 |
p. 168-179
|
article
|
| 3 |
Back Matter
|
|
|
|
141 |
2 |
p. II
|
article
|
| 4 |
Cannabidiol attenuates hyperalgesia in a mouse model of sickle cell disease
|
Cherukury, Hemanth M.
|
|
|
141 |
2 |
p. 203-208
|
article
|
| 5 |
COVID-19 prophylaxis: half-full or half-empty glass?
|
Scarfò, Lydia
|
|
|
141 |
2 |
p. 130-132
|
article
|
| 6 |
(De)ironing out sickle cell disease
|
Das, Nupur K.
|
|
|
141 |
2 |
p. 129-130
|
article
|
| 7 |
Dietary iron restriction protects against vaso-occlusion and organ damage in murine sickle cell disease
|
Li, Huihui
|
|
|
141 |
2 |
p. 194-199
|
article
|
| 8 |
Editorial Board
|
|
|
|
141 |
2 |
p. ix
|
article
|
| 9 |
Efficacy of tixagevimab-cilgavimab in preventing SARS-CoV-2 for patients with B-cell malignancies
|
Davis, James A.
|
|
|
141 |
2 |
p. 200-203
|
article
|
| 10 |
Enasidenib vs conventional care in older patients with late-stage mutant-IDH2 relapsed/refractory AML: a randomized phase 3 trial
|
de Botton, Stéphane
|
|
|
141 |
2 |
p. 156-167
|
article
|
| 11 |
How I treat thrombotic microangiopathy in the era of rapid genomics
|
Doreille, Alice
|
|
|
141 |
2 |
p. 147-155
|
article
|
| 12 |
IDH2 inhibition in AML
|
Stein, Eytan M.
|
|
|
141 |
2 |
p. 124-125
|
article
|
| 13 |
Is CBD ready for prime time in sickle cell disease?
|
Curtis, Susanna A.
|
|
|
141 |
2 |
p. 132-133
|
article
|
| 14 |
Malignant T cells induce skin barrier defects through cytokine-mediated JAK/STAT signaling in cutaneous T-cell lymphoma
|
Gluud, Maria
|
|
|
141 |
2 |
p. 180-193
|
article
|
| 15 |
Masthead Subscription
|
|
|
|
141 |
2 |
p. iv
|
article
|
| 16 |
Missense mutations in PIEZO1, which encodes the Piezo1 mechanosensor protein, define Er red blood cell antigens
|
Karamatic Crew, Vanja
|
|
|
141 |
2 |
p. 135-146
|
article
|
| 17 |
PIEZO1: now also featuring blood group antigens
|
Gassner, Christoph
|
|
|
141 |
2 |
p. 123-124
|
article
|
| 18 |
Table of Contents
|
|
|
|
141 |
2 |
p. vii-viii
|
article
|
| 19 |
TOXic T-cell cytokines wreak havoc in CTCL skin
|
Schlapbach, Christoph
|
|
|
141 |
2 |
p. 127-128
|
article
|
| 20 |
Ups and downs in the treatment of sickle cell disease
|
Brousse, Valentine
|
|
|
141 |
2 |
p. 125-127
|
article
|
Journal description